Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Does Continuous Cefotaxime Administration Improve Time to Attainment and Maintenance of Target Drug Levels in Critically Ill Patients?

NCT02560207 is registered in ClinicalTrials.gov with University Medical Center Groningen as lead sponsor.

NCT NCT02560207
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02560207 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Does Continuous Cefotaxime Administration Improve Time to Attainment and Maintenance of Target Drug Levels in Critically Ill Patients?
Lead sponsor
University Medical Center Groningen
Phase
Phase 4
Overall status
Completed
Start date
November 30, 2015
Completion date
September 30, 2016
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

critically ill